EMFAT
TARS icon

Emerald Mutual Fund Advisers Trust’s Tarsus Pharmaceuticals TARS Stock Holding History

Emerald Mutual Fund Advisers Trust’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-109,692
Closed -$3.61M – 238
2024
Q3 		$3.61M Buy
+109,692
New +$3.08M 0.19% 109

Other funds holding TARS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's TARS Position: Q4 2024 in Review

Emerald Mutual Fund Advisers Trust sold out of Tarsus Pharmaceuticals (TARS) in Q4 2024, closing a stake of 109,692 shares — an estimated $3.61M sold.

Emerald Mutual Fund Advisers Trust first reported a position in TARS in Q3 2024 and held it in 1 quarter. The position peaked at $3.61M in Q3 2024. 195 funds tracked by Wall St. Rank hold TARS as of Q4 2024.

  • Emerald Mutual Fund Advisers Trust reported no remaining Tarsus Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Emerald Mutual Fund Advisers Trust sold 109,692 Tarsus Pharmaceuticals shares in Q4 2024, an estimated $3.61M.
  • Emerald Mutual Fund Advisers Trust first reported a position in Tarsus Pharmaceuticals in Q3 2024 and held it in 1 quarter.
  • Emerald Mutual Fund Advisers Trust's Tarsus Pharmaceuticals position peaked at $3.61M in Q3 2024.
  • 195 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q4 2024.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q4 2024, filed 14 Feb 2025.